Allied Health & Imaging · Independent exam preparation
Certified Transplant Preservationist (CTP®) Examination Study Guide
Study recovery preparation, preservation physiology, anatomical reasoning, specimen identification, and transport verification through selective concepts and original practice questions.
By CertMedbry · Updated 31 October 2026
Practise the decisions that protect organ identity, asepsis, preservation conditions, and transport continuity. This guide connects recovery preparation with anatomical reasoning, machine measurements, specimen handling, and package verification. Its 60 selective concepts address all five CTP domains. The official ABTC outline on handbook PDF pages 39–40 remains the full examination scope, including adult and pediatric donors, authorization, allocation policy, and all listed organ types.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
Which certification and professional pathway does this guide cover?
It covers the American Board for Transplant Certification’s Certified Transplant Preservationist (CTP®) Examination. ABTC requires 12 months of organ-preservation work experience; preservation need not be the candidate’s full-time responsibility. This is a professional preservation credential.
ABTC Certification Examinations · ABTC Candidate Handbook, filename dated August 13, 2026
How many questions are included, and how long is the examination?
The CTP examination contains 110 items and allows two hours. Responses to 100 items contribute to the score; 10 are unscored pretest items. Breaks do not add examination time.
How is the examination delivered?
The handbook describes computer administration at PSI Test Centers, with international testing potentially arranged. Candidates can move backward and forward, bookmark questions, and change responses. The cited handbook does not identify CTP as computer adaptive.
Which response format and cognitive levels are described?
The handbook describes selecting a response from four displayed choices. The scored CTP blueprint contains 36 recall, 56 application, and 8 analysis items. The 20 questions here use four options and one best answer; they are independent learning exercises rather than a complete examination simulation.
Which handbook version supports this guide?
The guide uses the handbook linked by ABTC and verified on October 31, 2026, whose filename is dated August 13, 2026. The CTP outline appears on PDF pages 39–40 without a CTP-specific effective date. Dates attached to neighboring examination outlines do not establish a CTP effective date.
ABTC Candidate Handbook download page · ABTC Candidate Handbook, filename dated August 13, 2026
How are the five domains weighted?
The published counts yield Professional Practice 15%, Organ Recovery 30%, Organ Preservation 25%, Specimen Collection 12%, and Organ Labeling and Packaging for Transport 18%, based on 100 scored items. Across those domains, this guide allocates concepts 9/17/16/7/11, questions 3/6/5/2/4, and flashcards 3/5/6/2/4.
How does CTP differ from the other ABTC examinations?
CTP emphasizes organ preservation and associated recovery, specimen, and transport responsibilities. CPTC addresses procurement coordination; CCTC addresses clinical transplant coordination; CCTN addresses transplant nursing; CTFC addresses transplant financial coordination. Each credential has its own eligibility rules and examination outline.
ABTC Certification Examinations · ABTC Candidate Handbook, filename dated August 13, 2026
Which jurisdiction and policy version support the transport material?
The CTP scope includes UNOS/OPTN allocation policy. This guide’s packaging and extra-vessel material uses U.S. OPTN Policies effective October 1, 2026, particularly Policy 16. These requirements are U.S. policy content rather than universal international law.
ABTC Candidate Handbook, filename dated August 13, 2026 · OPTN Policies Effective as of October 1, 2026
Can a practice result predict whether a candidate will pass?
No. The handbook describes criterion-referenced standard setting and an overall pass/fail decision. It does not supply a verified numerical CTP passing score for this guide. Results from these 20 learning questions identify topics for review and cannot predict certification success.
This guide addresses ABTC’s Certified Transplant Preservationist examination at the first-year transplant professional level. Its original questions and flashcards are independent educational materials and are not endorsed by ABTC. U.S. OPTN requirements are identified as U.S. policy content.
Outline used: Current ABTC Candidate Handbook linked by the issuer on 2026-10-13; filename dated 2026-08-13. CTP outline appears on PDF pages 39–40. No CTP-specific effective date is printed. The workbook label matches the verified credential.
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
Professional Practice15% (derived from 15 of 100 scored items)
1.How should responsibility transfer between recovery teams?
A responsibility transfer needs an identified sender, receiver, task, and confirmation of acceptance. Several teams participating in a case does not establish who owns an unfinished action. Package preparation, clinical acceptance, and transport coordination are related but separate responsibilities. An action described passively, such as “transport is arranged,” remains uncertain unless someone can confirm its status and communicate changes.
Apply it
When local and visiting staff each assume the other arranged ground transport, assign a named coordinator, confirm the booking, and communicate the pickup plan to both teams.
Common pitfall: A team’s presence does not establish task acceptance. Distinguish an anticipated action from a completed action confirmed by its owner.
ABTC Candidate Handbook, filename dated August 13, 2026 · AHRQ Overview of Key Communication Concepts and Tools
2.Why does removing a name alone fail to establish de-identification?
Dates, record numbers, photographs, locations, and distinctive narrative details can identify someone after a name is removed. HHS describes Safe Harbor and Expert Determination as distinct de-identification methods. Assess the complete educational record, including images and free text. Replacing a name with a pseudonym changes one field but does not establish that the remaining information satisfies either method.
Apply it
A teaching slide omits the donor’s name but retains an exact admission date, hospital number, and recognizable photograph. Address all remaining identifying information through an appropriate de-identification process before general educational use.
Common pitfall: Initials, cropped headings, and fictional names can leave direct identifiers elsewhere. A narrative may also remain identifiable through a distinctive combination of details.
HHS Guidance Regarding Methods for De-identification of Protected Health Information
3.How does allocation priority differ from recipient compatibility?
Under the standard U.S. OPTN allocation sequence, compatibility determines which candidates can be considered, while the applicable organ allocation policy establishes their order. A compatible candidate or convenient destination does not independently establish priority. Under Policy 5.4.B, if no program on the initial match run accepts, programs may update candidate data and the OPO must re-execute the match run. Any applicable exception requires its own policy basis.
Apply it
After the initial run produces no acceptance, a nearby program updates a candidate’s information. Use the updated information in the required allocation process rather than selecting the candidate solely because transport would be convenient.
Common pitfall: Compatibility, acceptance, and allocation priority answer different questions. Do not treat any one of them as proof that the others have been satisfied.
OPTN Policies Effective as of October 1, 2026 · ABTC Candidate Handbook, filename dated August 13, 2026
4.When does new equipment require demonstrated competency?
New equipment can change sterile connections, assembly steps, alarms, and contamination risks. Experience with an earlier device does not demonstrate performance with those changes. CDC calls for job-specific training before duties and additional training when equipment or procedures introduce new risks. A useful competency assessment observes the worker performing the relevant steps and recognizing errors, rather than recording attendance at an introductory presentation.
Apply it
A replacement perfusion set has unfamiliar sterile connectors. Observe assembly and contamination recognition with that set, correct errors, and document task-specific competence before independent setup.
Common pitfall: Years of service demonstrate experience, while an attendance sheet demonstrates participation. Neither establishes that a person can correctly perform newly introduced steps.
5.How should evidence be matched to its actual indication?
Evidence applies to the population, organ, device, and conditions it addresses. A kidney transport device’s regulatory summary does not establish settings or suitability for pancreas, intestine, or VCA preservation. Distinguish intended use, monitored variables, physiological explanation, and policy requirements. Before applying information, identify the question it actually answers and whether the proposed use extends beyond that support.
Apply it
A colleague proposes applying kidney-device pressure information to a pancreas. Identify the organ and device mismatch and establish support for the proposed application before adding it to the preservation plan.
Common pitfall: Similar terminology does not establish interchangeable use. A plausible mechanism, device clearance, and allocation rule provide different kinds of evidence and cannot substitute for each other.
FDA K211333: Kidney Assist-transport 510(k) Summary · ABTC Candidate Handbook, filename dated August 13, 2026
6.What should a preprocedure brief establish?
A brief establishes a shared plan before work starts. It identifies goals, roles, available resources, expected events, and likely contingencies. During recovery preparation, it makes assumptions about equipment, flush control, specimen handling, event recording, and transport visible. A useful brief produces explicit assignments and anticipated responses to change. Reading a list without checking responsibilities does not establish that participants understand the same operational plan.
Apply it
Before multiorgan recovery, confirm each team’s expected work and critical handoffs. Identify who controls flush initiation, who records events, and how changes will reach the other teams.
Common pitfall: Silence can conceal different assumptions. Named assignments and explicit contingencies make the brief useful when the case becomes time-sensitive.
7.When should a huddle revise the recovery plan?
A huddle addresses an active change that makes the original shared plan incomplete or unsuitable. Equipment failure, a changed sequence, or a transport delay can affect several teams simultaneously. Bring affected personnel together, describe the change, identify consequences, and assign revised actions. The result should be a renewed shared understanding of current work. A huddle therefore differs from the initial brief and the later debrief.
Apply it
The expected preservation machine becomes unavailable. Establish the revised preservation approach, replacement resources, responsible personnel, and effects on timing before teams continue with incompatible assumptions.
Common pitfall: Separate private workarounds can conflict at shared handoffs. An equipment notice communicates a fact but may leave its operational consequences unresolved.
8.How does a debrief turn a near miss into an improvement?
A debrief compares intended performance with what happened and identifies changes for future work. Describe the observed sequence, contributing conditions, and safeguards that worked. Then select a specific action with an owner and an observable completion point. This approach preserves successful behaviors while addressing the conditions that produced the near miss. A general instruction to be careful provides little guidance about what should change.
Apply it
A second check catches an incorrect cooler label. Determine when labels became separated from containers, retain the successful verification step, and assign a specific improvement to workspace organization.
Common pitfall: Blaming the last person who touched the label can miss earlier contributing conditions. Improvement requires an actionable change rather than a vague reminder.
9.Why must authorization and allocation be considered separately?
Authorization establishes permission for a specified recovery activity or purpose. Allocation concerns placement under the applicable organ allocation system. Neither automatically establishes the other. A preservationist must recognize when a proposed recovery, research activity, or destination conflicts with the documented plan. Recipient need, organ availability, and an accepted offer do not independently establish that every proposed activity falls within authorization.
Apply it
An additional research recovery is requested after clinical allocation is settled. Identify the separate authorization and research-purpose questions before adding supplies or assigning that recovery activity.
Common pitfall: A clinically allocated organ does not create permission for unrelated research recovery. Likewise, authorization to recover an organ does not determine its allocation priority.
ABTC Candidate Handbook, filename dated August 13, 2026 · OPTN Policies Effective as of October 1, 2026
Organ Recovery30% (derived from 30 of 100 scored items)
10.How should authorization limits shape preoperative preparation?
Translate authorization into the actual organs and purposes included in the recovery plan. Compare that scope with proposed clinical and research activities before supplies are committed or tasks assigned. A discrepancy requires reconciliation by responsible personnel before the disputed activity proceeds. The presence of a signed document alone does not establish that its contents support every item on an equipment list or every late request.
Apply it
Research recovery appears on the supply list but is absent from the documented authorization scope. Pause that portion of preparation and reconcile the permitted activity with the coordinator.
Common pitfall: Do not infer scope from a signature, a routine supply list, or a previous case. Read the authorization against the particular planned action.
11.How should a donor identification discrepancy be resolved?
Identification requires a verified link among the donor, case documentation, and identifiers used for organs and specimens. When records disagree, establish which information is correct before using it. Compare authoritative case records with responsible personnel and trace the origin of the discrepancy. Making all documents display the same value is insufficient if that value has never been verified against the donor’s identity.
Apply it
Specimen labels and the recovery worksheet display different donor identifiers. Stop using the disputed labels, reconcile the records, and restore a verified identity chain before collection.
Common pitfall: Choosing the newest document or copying one identifier onto every form can produce consistent but incorrect records. Printing quality and familiarity do not establish accuracy.
12.What makes case supplies ready rather than merely present?
Supplies are ready when their identity, quantity, integrity, compatibility, and availability match the planned task. A sealed box in the room does not establish that the required usable component is inside. Preparation should address dependencies: a flush setup needs compatible connections and the intended solution, while packaging needs suitable barriers, containers, and labels. Identify unsuitable items early enough to correct the setup or revise the shared plan.
Apply it
Several cannula packages are present, but none matches the planned connection. Obtain compatible components and communicate any preparation delay before the sterile field depends on the missing item.
Common pitfall: An inventory can appear complete while an essential component is damaged or incompatible. Functional readiness requires checking how the items work together.
13.How should a pediatric donor change preparation decisions?
The CTP scope includes adult and pediatric donors. Preparation therefore requires checking equipment suitability, positioning, collection plans, and the anticipated procedure against the actual donor. An adult setup should not become the default simply because it is already stocked. Equipment selection and clinical instructions must fit the particular case. Pediatric preparation also requires explicit confirmation of assumptions that experienced staff may otherwise carry forward from adult recoveries.
Apply it
A cart stocked after an adult case arrives for a pediatric donor. Review components with the recovery team, replace unsuitable items, and confirm the planned setup before establishing the field.
Common pitfall: Smaller size does not justify automatically scaling every adult pressure, volume, or medication instruction. Do not create donor-specific parameters from size alone.
14.Why should positioning be confirmed before sterile preparation?
Positioning must support planned access while keeping lines, equipment, and working areas usable. An access problem discovered after sterile preparation may require disruptive movement and create opportunities for contamination. Review the intended procedure and subsequent equipment placement together. The relevant question is whether the current arrangement supports each anticipated step, including the work of other recovery teams, rather than whether it resembles a familiar room layout.
Apply it
A planned equipment location would obstruct another team’s access. Resolve the donor and equipment arrangement before preparation and confirm that the revised layout supports both teams’ work.
Common pitfall: A position suitable for one recovery may be unsuitable for another. Waiting until sterile instruments are arranged makes access conflicts harder to correct.
15.How should the workspace separate sterile and nonsterile tasks?
Arrange work so sterile handling does not require contact with nonsterile controls, paperwork, or transport surfaces. Anticipate how personnel and materials move from recovery through back-table handling and packaging. Nonsterile duties need accessible equipment and clearly assigned personnel. A contamination risk becomes apparent when the task sequence requires the same gloves or instruments to cross between areas with different contamination status without restoring the appropriate barrier.
Apply it
Documentation placement makes staff repeatedly reach across the back table. Relocate the paperwork and assign recording duties so event documentation can continue without crossing the sterile handling area.
Common pitfall: A room can contain every required item while forcing unsafe movement. Assess the sequence of actual work rather than equipment placement alone.
ABTC Candidate Handbook, filename dated August 13, 2026 · CDC Core Infection Prevention and Control Practices
16.How does tracing a flush line prevent delivery errors?
Tracing connects the intended solution source to the intended delivery point and identifies intervening clamps, connections, and controls. A source label alone does not establish where fluid will go. Verify the assembled route before use and after a relevant setup change. The physical arrangement must match the agreed plan, including who controls initiation. This checks the functional system rather than assuming that individually correct components guarantee a correct pathway.
Apply it
Two lines lie together after a setup change. Trace each from its labeled source to the designated connection, confirm controls with the team, and resolve ambiguity before use.
Common pitfall: Similar tubing and nearby connections can conceal a pathway error. Correct solution identity does not establish correct delivery when connections remain unverified.
18.How should cross-clamp and flush communications close the loop?
Closed-loop communication includes a clear message, the receiver’s repeat-back, and the sender’s confirmation or correction. During cross-clamp and flush events, identify the event, time, or instruction precisely. This prevents an announcement from being mistaken for a request or confirmation of a completed action. The sender should know what the receiver understood. A vague acknowledgement can indicate hearing without establishing agreement about the critical information.
Apply it
The recorder repeats the announced cross-clamp event and stated time. The surgeon confirms or corrects them before those details become the basis for the recovery record.
Common pitfall: An unanswered call-out leaves receipt uncertain. “Okay” does not confirm a particular numerical value, event identity, or instruction when those details matter.
AHRQ Tool: Check-Back or Repeat-Back · ABTC Candidate Handbook, filename dated August 13, 2026
19.How should medication preparation be distinguished from administration?
Medication preparation, handover, and administration are separate events. A prepared container establishes neither that its contents reached the donor nor when administration occurred. Communication should identify the intended medication and action, with confirmation of the completed event before it is recorded as administration. Maintain the distinction between an instruction, an acknowledgement, and evidence of completion. This supports accurate recovery documentation without inferring administration from supply use.
Apply it
An empty medication container is found after a handoff, but administration has not been confirmed. Reconcile the event with the responsible clinician before recording the medication and administration time.
Common pitfall: A preparation timestamp or empty container is not a verified administration timestamp. Do not substitute an inferred event for a confirmed clinical action.
ABTC Candidate Handbook, filename dated August 13, 2026 · AHRQ Tool: Check-Back or Repeat-Back
20.How should recovery intervals be calculated from timestamps?
An interval requires explicitly defined start and end events recorded on a consistent time basis. Cross-clamp, flush initiation, organ removal, and departure are different events and should retain their individual timestamps. Include dates when an interval crosses midnight. If records conflict, reconcile the event definitions and times before calculating. Selecting a convenient pair because it produces an expected duration can yield a mathematically correct answer to the wrong question.
Apply it
A defined interval runs from 23:48 to 00:17 the next day. Add 12 minutes to midnight and 17 minutes afterward to obtain 29 minutes, retaining the dates and event names.
Common pitfall: Clock displays without dates can produce a negative interval. Calling every recovery interval “ischemia time” can conceal different endpoint definitions.
21.What makes a flush observation useful to the receiving team?
A useful observation records what occurred, when it occurred, and the relevant pathway, setup, or change. Distinguish observable findings from a proposed cause or judgment about graft suitability. “Flush completed” can hide an interruption, changed connection, or unexpected delivery pattern. The description should let another professional reconstruct the event, identify the affected organ or pathway, and understand what action followed and who was informed.
Apply it
Delivery changes after line repositioning. Record the observed change, event time, line adjustment, and notification rather than documenting only that the planned flush was eventually completed.
Common pitfall: A reassuring summary can erase an important interruption. Conversely, an unexpected appearance alone does not establish its cause or justify a suitability conclusion.
22.Why must recovery attire be checked before sterile participation?
Attire and preparation must match the assigned task and contamination environment. Confirm readiness before a person enters or handles the sterile work area. The CTP outline includes recovery attire and surgical preparation. Clothing that appears clean does not establish a sterile barrier, and arrival in the operating room does not establish completion of gowning and gloving. Evaluate the person’s readiness for the particular activity being requested.
Apply it
A late-arriving assistant is asked to help at the back table before completing preparation. Complete the appropriate sequence first or assign an immediate nonsterile task instead.
Common pitfall: Urgency and familiarity with a colleague do not establish sterile readiness. A clean-looking garment cannot be treated as sterile simply because the task is brief.
ABTC Candidate Handbook, filename dated August 13, 2026 · CDC Core Infection Prevention and Control Practices
23.How should anticipated exposure determine PPE selection?
PPE selection follows the expected exposure and body surfaces at risk. Gloves address hand contact; anticipated blood or body-fluid splash may also require protection for clothing, skin, eyes, nose, and mouth. CDC links selection to the interaction rather than job title. A task involving pressurized or fluid-containing tubing therefore requires assessment of splash direction and extent, even if the worker expects the hands to control the tubing.
Apply it
Before a disconnection likely to splash toward the face, select appropriate facial and body protection as well as gloves and arrange the task to reduce splashing.
Common pitfall: Gloves do not protect facial mucous membranes. Brief exposure duration and experience with the task do not remove the need to match barriers to exposure.
24.What does surgical hand antisepsis accomplish before gloving?
Surgical hand antisepsis reduces organisms on the hands and limits their release if gloves develop a defect. CDC describes removing jewelry and cleaning beneath nails before the surgical preparation, then following the chosen product’s instructions. Sterile gloves provide a barrier but do not make organisms beneath that barrier irrelevant. The preparation method must correspond to the surgical task rather than being replaced by ordinary glove application.
Apply it
A staff member proposes skipping surgical hand preparation because two glove layers will be worn. Complete the specified antisepsis before donning the sterile gloves.
Common pitfall: Additional glove layers do not complete omitted hand preparation. A barrier can develop a defect, so appropriate preparation beneath it remains relevant throughout the procedure.
25.When may sterile gloves follow an alcohol-based surgical preparation?
After applying an alcohol-based surgical hand product as directed, allow hands and forearms to dry before donning sterile gloves. CDC also specifies drying after the prewash before alcohol application in that preparation sequence. Residual wetness indicates that the drying step remains incomplete. Product instructions determine the sequence; a ready field, approaching procedure time, or available gloves does not change the required completion criteria.
Apply it
Your hands remain wet when the field is ready. Allow drying to finish before gloving while another prepared team member handles any immediate sterile task.
Common pitfall: Application alone does not complete the preparation. Do not shorten drying or add an unverified wiping step to accelerate entry into the sterile field.
26.How should a recognized sterile glove breach change handling?
A recognized breach compromises the hand barrier and requires assessment of subsequent contacts. Stop the affected sterile handling and communicate what occurred. Remove the compromised gloves safely, avoiding contamination of bare skin, perform hand hygiene, and allow hands to dry completely. Restore sterile protection with new sterile gloves and replace any other compromised barriers before resuming handling. Identify materials touched after the breach so the team can address their contamination status. Absence of visible fluid does not establish that the breached barrier remained protective.
Apply it
After touching a nonsterile control, you notice a glove defect. Stop and report the contact, remove the gloves safely, perform hand hygiene, dry completely, and restore sterile protection. Assess any materials touched after the breach before they are used further.
Common pitfall: Wiping or washing a disposable glove does not restore sterility. Changing gloves without hand hygiene omits cleaning after barrier failure; resuming before complete drying and restoration of sterile protection leaves the corrective sequence incomplete.
CDC Clinical Safety: Hand Hygiene for Healthcare Workers · CDC Core Infection Prevention and Control Practices · ABTC Candidate Handbook, filename dated August 13, 2026
27.How should decanting protect the contents and receiving field?
Decanting must preserve separation between sterile contents and nonsterile package surfaces. Establish who controls the source container, who handles the sterile receiving area, and how transfer avoids compromising contact. Assess the complete pathway, including the receiving vessel. The original sterility of a solution cannot compensate for a contaminated basin, unsuitable transfer contact, or an unresolved break in the receiving field.
Apply it
A solution is ready to pour, but the basin’s sterility is uncertain. Replace or reestablish the receiving setup and coordinate the transfer roles before pouring.
Common pitfall: Sterile contents do not make the package exterior sterile. Opening an intact container does not guarantee that every subsequent transfer preserves the contents’ original status.
ABTC Candidate Handbook, filename dated August 13, 2026 · CDC Core Infection Prevention and Control Practices
Organ Preservation25% (derived from 25 of 100 scored items)
17.Which common cannulation and cross-clamp sites define preservation territories?
In common cold-recovery anatomy, the infrarenal aorta just above its bifurcation provides access for abdominal arterial flush. A supraceliac clamp, above the celiac origin, or a descending thoracic clamp confines that territory proximally. Cardiac perfusion enters the aortic root toward the coronaries; pulmonary perfusion enters the main pulmonary artery toward the lungs. Ascending aortic cross-clamping separates the cardiac root from downstream aortic circulation. These examples are described in [TSANZ/ADTCA surgical guidance](https://trial.tsanz.com.au/storage/documents/TSANZ_SurgicalTechniqueForDeceasedDonorABDO_Version-11_02FINAL.pdf).
Apply it
An accessory renal artery arises near the proposed distal aortic cannulation site. Recognize its renal territory and alert the surgeon because placement could exclude or injure that branch.
Common pitfall: Common landmarks support recognition. Actual branch anatomy and the organs being recovered determine the surgeon’s selected sites and sequence.
ABTC Candidate Handbook, filename dated August 13, 2026 · NHLBI How Blood Flows through the Heart
28.Why should cooling and perfusion be assessed separately?
Cooling reduces metabolic activity, while perfusion moves solution through the vascular pathway. They describe different preservation functions. A cold organ or acceptable temperature does not demonstrate that fluid is reaching the intended vessels. Conversely, displayed flow does not establish that the intended temperature is maintained. The kidney transport device summary identifies temperature, pressure, flow, and resistance as separate monitored variables, supporting assessment of the complete preservation pattern.
Apply it
Temperature remains stable while flow decreases after tubing movement. Assess the flow change and physical pathway instead of treating stable cooling as proof that preservation delivery is unchanged.
Common pitfall: One satisfactory variable cannot establish the status of another function. Neither cold appearance nor maintained flow independently demonstrates complete organ function or graft suitability.
FDA K211333: Kidney Assist-transport 510(k) Summary · ABTC Candidate Handbook, filename dated August 13, 2026
29.Which circulation supplies the heart muscle itself?
The coronary arteries supply the myocardium and arise from the aorta. This pathway differs from blood moving through the heart’s chambers toward the lungs or systemic circulation. When identifying a vessel, establish whether it supplies the myocardium, returns blood to a chamber, or participates in pulmonary circulation. The distinction prevents a vessel near the heart from being assigned a function simply because it enters or leaves the organ.
Apply it
A learner identifies the pulmonary artery as the origin of myocardial arterial supply. Trace the coronary origins from the aorta and contrast that route with right ventricular outflow toward the lungs.
Common pitfall: Blood passing through cardiac chambers is not the same pathway as coronary arterial supply. Anatomical proximity does not establish a vessel’s physiological role.
30.How do pulmonary blood flow and ventilation meet at the alveoli?
Airways deliver air to alveoli, and pulmonary arterial branches deliver blood to surrounding capillaries. Oxygen moves into blood while carbon dioxide moves toward alveolar air. These are coordinated but separate pathways. Distinguish a bronchus from a vessel and identify the direction of blood movement. Artery describes flow away from the heart; pulmonary arterial blood therefore need not share the oxygen content usually associated with systemic arteries.
Apply it
A learner says a bronchus carries blood from the right ventricle. Separate the airway route from pulmonary arterial flow and identify their functional meeting point at the alveolar-capillary interface.
Common pitfall: Pulmonary arteries carry oxygen-poor blood toward the lungs. Applying the systemic artery–oxygen association without considering the circuit reverses the relevant physiological relationship.
NHLBI How the Lungs Work: The Respiratory System · NHLBI How Blood Flows through the Heart
31.How are renal vascular flow and urinary drainage distinguished?
Blood enters through renal arterial vessels and leaves through the renal vein. Urine drains through the ureter toward the bladder. These structures represent different pathways even when discussed together at the renal hilum. Describe the actual structure and its function rather than using “tube” or “outflow” without qualification. A finding affecting venous drainage cannot automatically be interpreted as a finding affecting urinary drainage.
Apply it
A handoff uses “outflow” for both a vessel joining the inferior vena cava and a conduit toward the bladder. Clarify them as renal venous return and ureteric drainage.
Common pitfall: A vein and ureter both carry material away from the kidney, but their contents, destinations, and functions differ. Direction alone does not establish identity.
32.Why does glomerular filtration differ from final urine production?
The glomerulus filters fluid and small substances from blood into the nephron. Tubular processing returns needed water and substances to blood and contributes to waste handling. Final urine therefore reflects filtration plus subsequent processing rather than the entire initially filtered volume. These distinct functions also explain why movement of perfusate through renal vessels is not, by itself, proof of complete filtration and tubular performance.
Apply it
A learner assumes every unit of filtered fluid becomes urine. Draw the nephron and show return of water and needed substances from the tubule to blood.
Common pitfall: Vascular flow, glomerular filtration, and final urine output are different observations. Do not substitute evidence of one process for demonstrated performance of the others.
33.Why is the hepatic portal vein an inflow vessel for the liver?
The hepatic portal vein brings blood from abdominal organs, including the intestines, spleen, pancreas, and gallbladder, toward the liver. Its name does not make it hepatic outflow. Direction must be described relative to the organ under discussion: blood can leave an abdominal organ and subsequently enter the liver through the portal circulation. Naming the vessel and reference organ prevents ambiguous descriptions of venous flow.
Apply it
A handoff describes portal blood as leaving the liver because it travels in a vein. Correct the direction by tracing blood from abdominal organs toward the liver.
Common pitfall: Artery and vein do not independently define inflow and outflow for every organ. Portal venous flow is hepatic inflow despite being venous blood.
34.How do the pancreas’s endocrine and exocrine functions differ?
The endocrine pancreas secretes hormones into blood. Insulin promotes cellular glucose uptake and lowers blood glucose; glucagon promotes release of stored glucose from the liver and raises blood glucose. The exocrine pancreas produces digestive enzymes delivered through ducts to the small intestine, where they help break down carbohydrates, fats, and proteins. Hormonal secretion and ductal digestive secretion therefore have different destinations and functions.
Apply it
A learner says pancreatic enzymes lower blood glucose by entering the bloodstream. Correct both links: insulin provides the glucose-lowering hormonal action, while digestive enzymes travel through ducts to act on food in the intestine.
Common pitfall: An artificial pancreas system supports glucose regulation through monitored insulin delivery. It does not reproduce pancreatic digestive-enzyme secretion or establish the condition of a whole pancreas graft.
What is the pancreas? What is an artificial pancreas device system? | FDA · Your Digestive System & How it Works - NIDDK
35.How does the small intestine convert luminal nutrients into absorbed nutrients?
Digestion breaks food into absorbable components, while absorption moves those components across the intestinal lining. The small intestine mixes food with pancreatic, hepatic, and intestinal secretions and absorbs most nutrients. Simple sugars and amino acids enter blood and travel toward the liver; the lymphatic system absorbs fatty acids and certain vitamins. Peristalsis moves and mixes contents, but movement alone does not demonstrate absorption.
Apply it
A learner equates visible bowel movement with nutrient uptake. Trace digested sugar from the lumen across the intestinal lining into blood, then toward the liver. Contrast that pathway with lymphatic uptake of fatty acids.
Common pitfall: Luminal digestion, muscular movement, mucosal absorption, and vascular transport are distinct functions. Demonstrating one does not establish that the others are intact.
Your Digestive System & How it Works - NIDDK · NCI Dictionary: Hepatic Portal Vein
36.Why does a hand VCA require both vascular continuity and preservation of other structures?
A hand VCA contains multiple tissues, including skin, bone, nerves, and blood vessels, recovered and transplanted as an anatomical unit. Arterial inflow and venous return support its living tissues; bone fixation and tendon and nerve repair address separate structural and functional relationships. [HRSA’s hand-transplant explanation](https://www.organdonor.gov/learn/what-can-be-donated/face-hands) describes these distinct repairs. OPTN’s VCA definition requires surgically connected blood flow and recognizes susceptibility to ischemia.
Apply it
For a hand graft, an arterial connection is documented but venous drainage and an injured tendon remain unclear. Identify three separate issues: delivery into the graft, return from it, and continuity of the tendon. One documented connection cannot resolve all three.
Common pitfall: Visible skin integrity or a recorded arterial connection does not establish adequate circulation through every included tissue or intact tendon and nerve relationships.
ABTC Candidate Handbook, filename dated August 13, 2026 · OPTN Policies Effective as of October 1, 2026
37.How should a preservation-solution temperature excursion be evaluated?
Compare the documented exposure with the product’s labeled storage conditions. Current refrigeration, normal appearance, and an intact seal do not establish that an earlier excursion was harmless. FDA states that products are unsafe when their specific storage requirements have been violated. Distinguish a confirmed violation from incomplete exposure information; uncertain suitability requires investigation and appropriate quality evaluation rather than an assumption based on the present temperature.
Apply it
A logger documents overnight storage beyond the labeled limit. Exclude the affected solution from available stock even though it is cold again and looks unchanged.
Common pitfall: Recooling changes current temperature, not exposure history. Visual inspection addresses only observable features and cannot establish stability after a documented storage violation.
38.Why must solution identity be checked separately from integrity and temperature?
Solution identity, container integrity, sterility, and temperature history answer different questions. A chilled, intact container can still hold a formulation different from the one specified for the planned preservation method. Conversely, the correct formulation can become unsuitable through contamination or a storage violation. Confirm each property independently and match the solution to the intended organ and equipment rather than treating a familiar product name or package appearance as sufficient.
Apply it
Two similarly named solutions are chilled and intact. Verify the formulation specified for the planned system, then assess its seal, labeling, expiry information, and storage history separately.
Common pitfall: Acceptable temperature does not establish correct composition or sterility. A correct formulation also cannot compensate for a damaged container or documented failure to meet storage requirements.
ABTC Candidate Handbook, filename dated August 13, 2026 · FDA K211333: Kidney Assist-transport 510(k) Summary · FDA Medical Devices Requiring Refrigeration
39.Why does pressure alone fail to describe flush delivery?
Pressure describes a driving condition, while flow describes fluid movement over time. Their relationship depends on resistance, so an unchanged pressure can accompany a changed flow. The kidney transport device summary identifies these as separate monitored variables. Distinguish measured pressure from a selected target and assess related measurements and the physical pathway when delivery changes. Raising a setting merely to recover a familiar flow value does not explain the change.
Apply it
Measured pressure remains stable while flow declines after tubing is moved. Report both values and assess the altered pathway before the responsible operator considers any adjustment.
Common pitfall: A familiar pressure display can conceal altered delivery. A target setting also cannot substitute for the measured pressure required by an assessment or calculation.
FDA K211333: Kidney Assist-transport 510(k) Summary · ABTC Candidate Handbook, filename dated August 13, 2026
40.Which machine measurements should be interpreted together?
The cited kidney transport system monitors pressure, flow, resistance, and temperature. Interpret them together with event times and operating conditions. A change may relate to the circuit, measurement conditions, or organ-related factors; an isolated number does not identify its cause. Preserve trends and relevant interventions so the responsible team can compare observations obtained under comparable conditions and recognize when the pattern changed.
Apply it
Flow changes after a connection adjustment. Record the corresponding pressure, resistance, temperature, and event time and communicate the complete pattern to the responsible operator.
Common pitfall: A favorable single value does not establish graft suitability. A trend can also mislead when values come from different settings or undocumented changes in the circuit.
41.How can a supplied resistance equation clarify a perfusion trend?
When resistance is defined as pressure difference divided by flow, use the supplied equation and units. At an unchanged pressure difference, decreasing flow increases calculated resistance. The result describes a mathematical relationship rather than a diagnosis or acceptance threshold. Confirm that the pressure is the relevant measured difference and that both measurements refer to the same observation period before comparing results.
Apply it
With pressure difference 24 and flow declining from 120 to 80, resistance changes from 0.20 to 0.30 in the stated units. The increase is 50%, but its cause remains unestablished.
Common pitfall: Do not substitute target pressure for measured pressure difference. Correct arithmetic cannot establish irreversible injury, identify an obstruction, or determine graft suitability by itself.
FDA K211333: Kidney Assist-transport 510(k) Summary · ABTC Candidate Handbook, filename dated August 13, 2026
42.How should an abrupt machine-flow change be investigated?
An abrupt change requires assessment of the measurement pattern, recent events, and physical circuit. Compare flow with contemporaneous pressure, resistance, and temperature, then identify changes in tubing position or connections. Communicate the observations to the responsible operator and reassess after any authorized correction. A temporal relationship helps direct investigation but does not prove causation. Neither a stable temperature nor a continuing display establishes that delivery remains appropriate.
Apply it
Flow falls immediately after tubing repositioning while pressure and temperature remain stable. Report the full pattern, inspect the changed pathway with the operator, and document the response and reassessment.
Common pitfall: Do not automatically increase pressure, dismiss the change because cooling continues, or diagnose graft injury from one pattern. Each conclusion exceeds what the observations establish.
Specimen Collection12% (derived from 12 of 100 scored items)
43.How can a laboratory requisition determine which blood specimen is acceptable?
Consider a hypothetical HLA DNA-typing requisition that accepts only at least 4 mL of whole blood in a securely closed plastic EDTA collection tube, with no added transport medium, held at 2–8°C and received within 24 hours of collection. Evaluate material, quantity, container and additive, medium, temperature, and elapsed time separately. These are the exercise’s supplied laboratory specifications, not universal HLA-testing requirements.
Apply it
Choose 5 mL of EDTA whole blood in the specified tube, continuously held at 4°C and arriving after 10 hours. A 5 mL serum specimen fails the material requirement; 2 mL of EDTA blood fails quantity; an otherwise matching tube arriving after 30 hours fails timing.
Common pitfall: Correct donor identification cannot compensate for unacceptable material or handling. Apply every supplied acceptance criterion rather than choosing the specimen with the most familiar tube.
44.How do specimen-label requirements differ for deceased and living donors?
For deceased-donor specimens, U.S. OPTN Policy 16.3.C requires a label secured to each separate specimen container during normal transport. Ordinarily, it must include donor ID plus at least one of: locally assigned unique ID, donor date of birth, or donor initials. For deceased-donor specimens, collection date/time, tissue type, and known blood type and applicable allocation subtype should also be included; this section distinguishes those recommendations from mandatory identifiers. During preliminary evaluation, if donor ID or blood type is unavailable, initial screening specimens may travel with a locally assigned unique ID plus one other identifier. The OPO must document all unique identifiers used to label tissue-typing specimens in its donor record. Living-donor samples have additional mandatory labeling requirements under Policy 16.1(4): blood type and applicable subtype, tissue type, and collection date and time.
Apply it
Two unlabeled deceased-donor tubes share a correctly labeled bag. Establish identification on each tube. For an initial screening specimen collected before donor ID is available, use the permitted alternative identifiers and document them so later results can be linked to the donor. For living-donor samples, also verify the mandatory blood type/subtype, tissue type, and collection date/time.
Common pitfall: Outer-package labels cannot replace container labels. Do not extend the deceased-donor mandatory/recommended distinction to living-donor samples or apply the initial-screening exception indiscriminately to later shipments.
45.How can supplied acceptance criteria distinguish suitable lymph-node and spleen specimens?
Consider a hypothetical donor-cell crossmatch requisition accepting at least 1 cm³ of fresh lymph node or spleen in a sterile, leak-proof screw-cap container, immersed in the laboratory-supplied RPMI medium, held at 2–8°C, and received within 12 hours. It excludes fixed tissue. These specifications belong only to this exercise. Match the actual tissue and its measured quantity, container, medium, temperature history, and collection-to-receipt interval to every criterion.
Apply it
A 1.2 cm³ lymph node in the specified RPMI container, held at 4°C and received after six hours, meets the stated criteria. Equally sized spleen in formalin fails the medium and fixation criteria; a 0.2 cm³ node fails quantity; a node in an empty container lacks the specified medium.
Common pitfall: A donor-labeled container saying only “sample” leaves tissue identity unclear. Record the actual tissue and collection details, and keep these hypothetical acceptance specifications separate from OPTN’s mandatory identification rules.
ABTC Candidate Handbook, filename dated August 13, 2026 · OPTN Policies Effective as of October 1, 2026
46.How should extra-vessel handling protect the unused remainder?
Keep extra vessels unopened until needed and maintain a separate sterile vessel area. HRSA guidance describes unused sterile forceps and regloving after incision before securing needed vessels. Remove only the required material and protect the remainder in its original container. A vessel taken onto the operative field must not be returned to that protected remainder, even if it was not implanted and has no visible contamination.
Apply it
One vessel reaches the operative field but becomes unnecessary. Keep it separate when repackaging the vessels that remained protected on the separate sterile table.
Common pitfall: Unused for implantation does not mean eligible for return to storage. Returning an operative-field vessel can compromise the previously protected material in the original container.
47.Which infectious-test results prohibit extra-vessel storage?
U.S. OPTN Policy 16.6.B prohibits storage when the donor tests positive for HIV by antibody, antigen, or NAT; HBsAg; HBV NAT; or HCV antibody or NAT. These are alternative listed findings, not a requirement for every test to be positive. Positive HCV antibody therefore remains a storage prohibition when HCV NAT is negative. Storage eligibility must also be distinguished from a separate clinical-use decision.
Apply it
A donor has positive HCV antibody and negative HCV NAT. Keep unused vessels out of stored inventory because the positive antibody meets a listed prohibition.
Common pitfall: Do not let negative NAT cancel a separately listed positive result. An anticipated transplant-related use does not create an exception to the storage exclusion.
48.How should stored extra vessels be monitored and retired?
U.S. OPTN policy requires secured, temperature-monitored refrigeration from 2°C through 8°C, appropriate preservation solution, a storage log, and daily security and temperature checks. A designated person oversees storage and disposition. Unused vessels must be destroyed within 14 days after recovery, and disposition reported within seven days of use, sharing, or destruction. The original recovery date anchors the destruction deadline even when vessels arrive later.
Apply it
A vessel container arrives three days after recovery. Enter the original recovery date, preserve its deadline, verify storage conditions, and assign documented daily checks.
Common pitfall: Arrival, transfer, or repackaging does not restart the recovery-based period. A current refrigerator display does not replace daily monitoring records or inventory oversight.
49.When may extra vessels be used or shared?
Extra vessels are restricted to organ transplantation or modification of an organ transplant. Eligible deceased-donor vessels may be shared between transplant hospitals under U.S. OPTN policy, subject to applicable restrictions. Living-donor extra vessels are limited to the original intended recipient and cannot be shared. Extra vessels from a donor with HIV are also limited to the original intended recipient. Inventory decisions therefore require donor-category and recipient-linkage information.
Apply it
Another hospital requests a living-donor vessel for an unrelated patient. Recognize the original-recipient restriction and retain that linkage in the inventory and disposition records.
Common pitfall: Physical availability and acceptable packaging do not establish permission to share. Do not extend deceased-donor sharing provisions to living-donor vessels or overlook infectious-test storage restrictions.
Organ Labeling and Packaging for Transport18% (derived from 18 of 100 scored items)
50.How are triple sterile barriers and rigid containers distinguished?
U.S. OPTN policy requires a triple sterile barrier for organs. A rigid container must form one layer for kidneys, pancreas, and extra vessels packaged separately from organs. A sterile rigid container can count as one of the three sterile layers. The external shipping box does not become a sterile barrier merely because it is rigid. Assess barrier status, rigidity, and external transport protection as separate properties.
Apply it
A kidney is enclosed in a sterile rigid container and two securely closed sterile bags. Count those three sterile layers and evaluate the external transport container separately.
Common pitfall: Three visible containers do not necessarily provide three sterile barriers. A nonsterile box cannot supply a missing sterile layer, regardless of its strength or insulation.
51.Where should the internal organ transport label be attached?
The standardized OPTN internal organ label attaches securely to the outermost layer of the triple sterile barrier or the mechanical preservation cassette holding the organ. It identifies the actual contents and donor, including blood type and subtype when used for allocation. Placement matters because the organ package may become separated from accompanying paperwork. A loose, accurate label cannot reliably identify the package to which it was intended to belong.
Apply it
A completed internal label lies beside a sealed package. Verify its information against the actual contents and attach it securely in the required location before final verification.
Common pitfall: Correct text in the wrong location can still produce an identification failure. Paperwork entries do not replace a securely attached label on the required package layer.
52.Which information makes the external label operationally useful?
The U.S. OPTN external label identifies the donor, specific contents, blood type and applicable subtype, sender name and telephone number, and Organ Center telephone number. It must remain secured under normal transport conditions. Contents and contact information serve different purposes: one identifies the shipment, while the other supports response to a delay or discrepancy. A routing address or color cue does not supply all required identification and response information.
Apply it
A container displays the correct organ name but lacks usable sender contact details. Complete and verify the required external label before the shipment is released.
Common pitfall: Destination information supports routing without proving donor identity. Color coding can assist recognition but does not replace required text or contact information.
53.How should source documentation accompany the organ?
Under U.S. OPTN Policy 16.4.A, deceased-donor organs must be accompanied by source documentation of donor blood type, subtype when used for allocation, and infectious disease testing results available at packaging. Place these documents in a watertight container in the designated documentation area or between the inner and external transport containers. Label the documentation container with the donor ID, blood type, and subtype when used for allocation. Complete this label through the OPTN tracking system unless an applicable policy exception applies. For living-donor organ shipments, Policy 16.1(3) additionally requires the donor's informed consent and complete medical record to accompany the required source documentation. These additional living-donor documentation requirements also apply to separately shipped living-donor extra vessels.
Apply it
A deceased-donor organ's documents are protected in a watertight pouch, but the pouch has no identification. Complete its required donor ID, blood type, and applicable subtype label through the OPTN tracking system unless an exception applies; watertight protection alone is insufficient. If living-donor extra vessels travel in a separate external container, prepare that shipment's required source documentation and include the donor's informed consent and complete medical record, even if those records already accompany the organ on another route.
Common pitfall: Check document contents, protection, placement, and documentation-container identification separately. An accurate label cannot compensate for missing documents, and a complete packet cannot compensate for an unlabeled deceased-donor documentation container. Electronic availability or documents accompanying a different shipment do not fulfill the requirement for documents to accompany this shipment. Do not omit living-donor informed consent or the complete medical record from separately shipped living-donor extra vessels.
54.How should independent package verification be performed?
After labeling and documentation are completed, a person other than the original labeler verifies accuracy, and verification is documented. The HRSA form describes two individuals, including an OPO staff member, checking donor identification, blood type sources, labels, and the organ in the correct container. Independence requires comparison with evidence and actual contents. Merely witnessing a signature or repeating the original labeler’s assurance does not perform that comparison.
Apply it
A colleague is asked to sign without checking the cooler. Complete the source, label, and contents comparison, resolve discrepancies, and document verification before departure.
Common pitfall: A second signature does not prove an independent check. Verification requires examining the completed work rather than assuming the first person’s conclusion is correct.
OPTN Policies Effective as of October 1, 2026 · Verification Form for Accuracy of Documentation and Packaging of Transplantable Organs
55.How should a temporary tracking-system outage be handled?
The host OPO normally uses the OPTN organ tracking system for deceased-donor packaging. When it is temporarily unavailable, U.S. OPTN policy requires a written alternative protocol that still fulfills Policy 16 and documentation of the reason for nonuse. The outage changes the workflow rather than the required safeguards. Identification, contents records, packaging, documentation, and verification must remain complete through the authorized alternative process.
Apply it
The system fails before packaging. Activate the OPO’s written alternative, record why it was needed, and complete all required checks before releasing the shipment.
Common pitfall: An outage does not suspend policy requirements. An improvised handwritten label is insufficient if the overall workaround omits required identification, documentation, or independent verification.
56.Which external container matches the transport arrangement?
U.S. OPTN policy distinguishes disposable shipping boxes, coolers, and mechanical preservation machines. Commercial shipment of organs or tissue-typing material requires a new disposable shipping box; those boxes cannot be reused. A cooler is permitted when a recovery-team member accompanies the organ to the transplant hospital. Mechanical preservation machines have separate reuse provisions. Select the package according to the actual arrangement rather than assuming every insulated container is interchangeable.
Apply it
Accompanied ground transport changes to unaccompanied commercial shipment. Reassess the external package and use a new compliant shipping box rather than retaining the already packed cooler automatically.
Common pitfall: Insulation alone does not establish suitability for the selected route. A transport change can alter packaging requirements even when the organ and destination remain unchanged.
57.Why are cooling, insulation, and leak containment separate checks?
Cooling material helps maintain temperature, insulation limits heat transfer, and secured leak-proof liners contain fluid. These functions are distinct, so adding ice does not repair inadequate insulation or a leaking liner. U.S. OPTN commercial-box requirements address these elements separately. Assess the completed package under expected transport conditions, including containment of cooling materials and protection of documentation, rather than relying solely on its temperature at departure.
Apply it
A box contains ample cooling material, but its liner cannot be secured. Correct containment and separately confirm insulation and documentation protection before dispatch.
Common pitfall: A cold package at departure provides one observation. It does not establish that the package will retain fluid, protect records, or maintain conditions throughout handling.
58.When may a transport machine or cooler be reused?
U.S. OPTN policy permits reuse of mechanical preservation machines and qualifying coolers after proper cleaning and sanitization and removal of previous donor-organ labels. These are separate requirements. A clean surface can still display misleading identification, while correct labeling does not establish adequate processing. Distinguish reusable external equipment from single-use sterile components; permission to reuse the machine does not establish permission to reuse every associated disposable item.
Apply it
A cleaned machine retains an old donor label beneath a handle. Remove previous identification, verify current labels, and separately confirm that sterile disposable components are appropriate for the new case.
Common pitfall: Covering an old label can leave conflicting information accessible. Neither relabeling nor external cleaning independently establishes readiness of the complete preservation setup.
OPTN Policies Effective as of October 1, 2026 · FDA K211333: Kidney Assist-transport 510(k) Summary
59.How should airline and airport screening plans be coordinated?
HRSA explains that organs may travel in an aircraft cabin or cargo compartment, while individual airlines determine acceptance and handling procedures. Confirm the actual carrier’s requirements rather than assuming a universal arrangement. At security, couriers should request a TSA supervisor or Passenger Support Specialist and provide relevant documentation, including screening sensitivities. The route plan must allow for screening as well as travel and transfer time.
Apply it
A flight is booked without checking organ acceptance procedures. Confirm the carrier’s arrangements, prepare documentation, and plan checkpoint assistance before the courier leaves for the airport.
Common pitfall: Medical importance does not create a universal screening exemption or guarantee cabin carriage. Procedures used successfully with another airline may not apply to this itinerary.
60.How does repackaging change a transplant hospital’s responsibilities?
A transplant hospital that repackages a deceased-donor organ for further transport must meet applicable U.S. OPTN packaging, labeling, and transport requirements and immediately notify the host OPO. It is not required to use the OPTN tracking system for that repackaging. Policy 16.1(2) exempts living-donor repackaging from notifying the member that originally packaged the organ. That notification exception does not remove applicable packaging, labeling, and transport obligations. The revised package still requires accurate identity, appropriate physical protection, accompanying documentation, and applicable verification.
Apply it
The hospital replaces a deceased-donor organ’s external container before onward shipment. Apply the required process to the revised package, verify contents and records, and immediately notify the host OPO. For living-donor repackaging, retain applicable packaging safeguards while recognizing the exception from original-packaging-member notification.
Common pitfall: Original verification does not automatically validate a changed shipment. Keep donor-category notification exceptions distinct from tracking-system exceptions and from the packaging requirements that continue to apply.
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Prioritize Organ Recovery and Organ Preservation, which together account for 55 of 100 scored blueprint items.
- Reconcile authorization, allocation priority, donor identity, equipment readiness, and the actual recovery plan before committing supplies or labels.
- Recognize common cannulation and cross-clamp landmarks and their perfusion territories. Distinguish coronary supply, pulmonary circulation, renal blood and urinary pathways, pancreatic secretion, intestinal absorption, and hand VCA structures.
- Interpret pressure, flow, resistance, and temperature together; distinguish calculations and observed trends from diagnoses or graft-suitability decisions.
- Trace contamination boundaries through hand preparation, sterile handling, solution transfer, specimen collection, and extra-vessel repackaging.
- Apply complete laboratory acceptance criteria and distinguish mandatory specimen identifiers from recommended label details. Learn U.S. OPTN transport and extra-vessel requirements while using the official outline as the full scope.
A practical preparation plan
1. Map the complete official outline
Use handbook PDF pages 39–40 as the master scope. Mark each task as familiar, partly familiar, or unfamiliar. Begin with the domain proportions 15/30/25/12/18, then increase attention to weaknesses without omitting a domain.
2. Rehearse a complete recovery
Describe authorization, allocation linkage, identification, equipment readiness, positioning, flush setup, event recording, specimen collection, preservation handoff, and packaging. At each transition, name the responsible person and evidence of completion.
3. Explain anatomy and measurements
Locate common cannulation and cross-clamp sites and trace their perfusion territories. Draw coronary, pulmonary, renal, and portal pathways; explain pancreatic secretion, intestinal absorption, and the tissue relationships in a hand VCA. Distinguish temperature, pressure, flow, and resistance, and practise calculations using defined equations and endpoints.
4. Analyse contamination and identification failures
Work through wet surgical preparation, glove breaches, unlabeled tubes, operative-field vessels, and conflicting labels. Identify the failed boundary, immediate corrective action, and evidence needed to restore a verified chain. Select specimens against every supplied laboratory acceptance criterion.
5. Review transport and extra-vessel requirements
Study OPTN Policy 16 with the verification form and HRSA vessel guidance. Compare external container types and distinguish vessel storage eligibility, contamination status, permitted use, and sharing restrictions.
6. Use practice to identify reasoning gaps
Answer the questions and explain why each alternative is less appropriate. Classify errors by anatomy, contamination, measurement, identification, authorization, or policy. Revisit the corresponding outline tasks and use flashcards for spaced recall.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- ABTC Certification Examinations
- ABTC Candidate Handbook download page
- ABTC Candidate Handbook, filename dated August 13, 2026
- ABTC Candidate Handbook, filename dated March 12, 2026
- OPTN Policies Effective as of October 1, 2026
- HRSA Organ Transport
- Verification Form for Accuracy of Documentation and Packaging of Transplantable Organs
- HRSA Guide to Handling and Repackaging Vessels
- CDC Clinical Safety: Hand Hygiene for Healthcare Workers
- CDC Core Infection Prevention and Control Practices
- FDA Medical Devices Requiring Refrigeration
- FDA K211333: Kidney Assist-transport 510(k) Summary
- HHS Guidance Regarding Methods for De-identification of Protected Health Information
- AHRQ Tool: Check-Back or Repeat-Back
- AHRQ Overview of Key Communication Concepts and Tools
- NIDDK Your Kidneys and How They Work
- NCI Dictionary: Hepatic Portal Vein
- NHLBI How Blood Flows through the Heart
- NHLBI How the Lungs Work: The Respiratory System
- What is the pancreas? What is an artificial pancreas device system? | FDA
- Your Digestive System & How it Works - NIDDK
- TSANZ_SurgicalTechniqueForDeceasedDonorABDO_Version-11_02FINAL.pdf
- 2020_consensusdocument_ishlt_donorheartandlungprocurement.pdf
- TSANZ_SurgicalTechniqueForDeceasedDonorABDO_Version-11_02FINAL.pdf
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.